{
    "title": "Astrazeneca eyeing merger with Dutch-US rival Acerta Pharma in bid to fight off threat from copy-cat drug makers",
    "url": "https://www.dailymail.co.uk/money/markets/article-3359808/Astrazeneca-eyeing-merger-Dutch-rival-Acerta-Pharma-bid-fight-threat-copy-cat-drug-makers.html",
    "date": "2015-12-14",
    "keywords": [
        "pharma",
        "drug",
        "takeover",
        "group",
        "astrazeneca",
        "yesterday",
        "cancer",
        "speculation",
        "tieup",
        "blood",
        "year",
        "share",
        "month",
        "shire",
        "step",
        "drive",
        "threat",
        "deal",
        "firmaz",
        "company",
        "treatmentan",
        "spokesman",
        "certainty",
        "transaction",
        "move",
        "attempt",
        "bid",
        "pfizer",
        "biotech",
        "shakeup",
        "firm",
        "cook",
        "pressure",
        "billionaire",
        "backer",
        "article",
        "az",
        "way",
        "competition",
        "potassium",
        "disease",
        "rival",
        "swoop",
        "angioedema",
        "treatment",
        "developer",
        "dyaxon",
        "baxalta",
        "offer",
        "approach",
        "equity",
        "slice",
        "industrys",
        "merger",
        "acquisition",
        "market",
        "talk",
        "investment",
        "running",
        "belgiandutch",
        "pain",
        "control",
        "skin",
        "treatmentsbut",
        "fagron",
        "executive",
        "quit",
        "funding",
        "capital",
        "increase"
    ],
    "category": [
        "money",
        "markets"
    ]
}